What You Should Know:
- New data from Nomi Health reveals a counterintuitive trend dubbed the "MSK Paradox": white-collar employees report significantly higher rates of musculoskeletal (MSK) disorders than their blue-collar counterparts.
- A national analysis of 435 employers showed that employees in office-based, professional roles had 38% higher MSK rates than skilled laborers. The study found that 27% of office workers reported incidents of back pain, compared to just 18% of
Read More
AbbVie Acquires Gilgamesh’s Psychedelic MDD Program For Up To $1.2B
What You Should Know:
- AbbVie and Gilgamesh Pharmaceuticals Inc. have announced a definitive agreement for AbbVie to acquire Gilgamesh's lead investigational candidate, bretisilocin, which is in clinical development for the treatment of patients with moderate-to-severe major depressive disorder (MDD).
- The deal is valued at up to $1.2B, which includes an upfront payment and development milestones. As part of the acquisition, Gilgamesh will spin off a new entity that will
Read More
Arcadia Report Reveals Data Gaps Hiding in High-Performing Health Plans
What You Should Know:
- Arcadia, a healthcare data platform, has announced the publication of its new research report, Scaling Smarter: The Data Strategies Powering High-Performing Health Plans. The report reveals a widening gap between the data capabilities that payers need and the tools, infrastructure, and analytics strategies that many still lack.
According to the report, a lack of a unified data foundation built around complete member 360 profiles can hinder the effectiveness
Read More
Humana Report Highlights Better Outcomes for Heart Failure Patients in Value-Based Care
What You Should Know:
- Humana Inc. has released a new Value-Based Care Issue Brief with findings that indicate value-based care delivers a higher quality of care and better medication adherence to evidence-based medicine for Medicare Advantage patients diagnosed with heart failure.
Impact of Heart Failture
Heart failure is a growing concern, with 11.4 million Americans expected to be diagnosed with the condition by 2050. Patients with heart failure are more likely to be
Read More
M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M
What You Should Know:
- Tempus AI, Inc., a technology company focused on advancing precision medicine with AI, has acquired Paige, an AI company specializing in digital pathology.
- The acquisition, valued at $81.25M, paid predominantly in Tempus common stock, is a strategic move to grow Tempus's dataset, expand its technical team, and strengthen its position in digital pathology.
A Comprehensive Dataset and Pioneering AI Applications
Since its founding in 2017, Paige has
Read More
KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction
What You Should Know:
- A new report from KLAS Research examines the state of Oracle Health three years after its acquisition of Cerner. The findings reveal that while Oracle Health has made big promises, customer satisfaction has not improved, and the vendor has lost a significant number of customers. The report is based on findings from seven rounds of interviews with a longitudinal feedback group of Oracle Health customers from 2022 to 2025.
- The report reveals a dissatisfied
Read More
Eko Health Appoints Dr. Jerome Adams as Distinguished Medical Advisor
What You Should Know:
- Eko Health, a company specializing in AI-powered cardiac and pulmonary detection, has announced that Dr. Jerome Adams, former U.S. Surgeon General, has joined the company as a Distinguished Medical Advisor.
- Dr. Adams brings with him decades of experience in clinical practice, public health, and policy leadership. His appointment comes at a time of accelerated company growth and a national focus on proactive, community-based early detection of cardiovascular
Read More
HGM Limited Acquires Aidéo Technologies to Expand AI-Driven RCM Platform
What You Should Know:
- HGM Limited, a global technology-driven enterprise focused on building AI-driven healthcare services, has announced that its wholly-owned U.S. subsidiary, Healthcare Capital Holdings LLC (HCH), has entered into a definitive agreement to acquire Aidéo Technologies LLC.
- HGM Limited, through its U.S. subsidiary, will acquire 100% of Aidéo Technologies LLC through an equity transaction. The acquisition is expected to close in August, subject to customary
Read More
Twin Health Secures $53M to Accelerate AI Digital Twin for Metabolic Health
What You Should Know:
- Twin Health, a company focused on using AI digital twin technology for metabolic health, has announced a $53M investment led by Maj Invest of Denmark.
- The new funding will be used to accelerate the company’s expansion among health plans and Fortune 500 clients in retail, healthcare, financial services, technology, and manufacturing.
A Smarter Path to Metabolic Health
Twin Health's approach challenges traditional metabolic health solutions
Read More
Wellth Secures $36M to Expand AI-Powered Behavior Change Platform
What You Should Know:
- Wellth, a digital health company specializing in combining daily motivation with behavior change strategies secures $36M in Series C financing led by Mercato Partners, with participation from FCA Venture Partners, Comcast Ventures, and existing investors.
- The funding will be used to expand access to the Wellth app across Medicare Advantage, Medicaid, D-SNP, and other high-need populations. The company will also use the funds to accelerate product innovation
Read More
